Neurovascular Device Market Poised For Growth

Published in MedTech Strategist, May 2018

Authors:  Dr. Oded Ben-Joseph and Seth Bensussen

Introduction:  

Not long ago, tPA was the only front-line treatment for acute ischemic stroke. But a second generation of mechanical thrombectomy devices, including stent retrievers and aspiration-based reperfusion devices, has demonstrated significant efficacy against ischemic stroke, providing the impetus for renewed device innovation and new care delivery strategies.

Next-generation mechanical thrombectomy devices will be the chief driver of growth in the neurovascular device market. New clinical data suggesting that interventional treatment even up to 24 hours after stroke onset is beneficial for some patients could almost triple the number of patients eligible for treatment.

View Full Article

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • New York

    555 Fifth Ave.
    19th Floor
    New York, NY 10017
    (212) 350-8213

  • Boston

    99 High St.
    Suite 2900
    Boston, MA 02110
    (617) 431-4886

  • Washington DC

    11921 Freedom Dr.
    Suite 730
    Reston, VA 20190
    (617) 431-4886

  • London

    78 Pall Mall
    London, SW1Y 5ES
    UK
    +44 207 873 2116